Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H44O3 |
Molecular Weight | 416.6365 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@]3([H])[C@]4([H])CC[C@@]5([H])C[C@@H](O)CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@@]6(CC[C@@H](C)CO6)O2
InChI
InChIKey=GMBQZIIUCVWOCD-MFRNJXNGSA-N
InChI=1S/C27H44O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28H,5-15H2,1-4H3/t16-,17+,18+,19+,20-,21+,22+,23+,24+,25+,26+,27-/m1/s1
Tigogenin is a saponin and acts as a natural plant steroid which induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes. This action is associated with overexpression of COX-2 correlated with overproduction of endogenous PGE2. In addition, it was found that through the inhibition of PPAR gamma and via the p38 MAPK pathway tigogenin has the potential to prevent the development of osteoporosis and the related disorders.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P37231|||Q15179 Gene ID: 5468.0 Gene Symbol: PPARG Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17363141 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17786275
Curator's Comment: Tigogenin was more effective than hecogenin in inducing apoptosis in human Rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) which was caspase dependent but poly(ADP-ribose) polymerase independent and characterized by DNA fragmentation. It was demonstrated, that tigogenin-induced apoptosis through activation of p38 without affecting the JNK and ERK pathways. Indeed, pretreatment with a p38 inhibitor decreased saponin-induced apoptosis with a significant decrease in DNA fragmentation. Furthermore, the rate of apoptosis induced by tigogenin was associated with overexpression of COX-2 correlated with overproduction of endogenous PGE2.
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
201-041-9
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY | |||
|
DTXSID40903920
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY | |||
|
9595
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY | |||
|
4SMU15RR44
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY | |||
|
99516
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY | |||
|
93754
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY | |||
|
m10861
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
77-60-1
Created by
admin on Sat Dec 16 09:06:07 GMT 2023 , Edited by admin on Sat Dec 16 09:06:07 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD